A defined subunit vaccine that protects against vector-borne visceral leishmaniasis

Vaccine development for vector-borne pathogens may be accelerated through the use of relevant challenge models, as has been the case for malaria. Because of the demonstrated biological importance of vector-derived molecules in establishing natural infections, incorporating natural challenge models i...

Descripción completa

Detalles Bibliográficos
Autores principales: Duthie, Malcolm S., Pereira, Lais, Favila, Michelle, Hofmeyer, Kimberly A., Reed, S. Jim, Metangmo, Sonia, Townsend, Shannon, Laurance, John D., Picone, Alessandro, Misquith, Ayesha, Hossain, Faria, Ghosh, Prakash, Khan, Md Anik Ashfaq, Guderian, Jeffery, Bailor, H. Remy, Liang, Hong, Vergara, Julie, Oliveira, Fabiano, Howard, Randall F., Kamhawi, Shaden, Mondal, Dinesh, Coler, Rhea N., Valenzuela, Jesus G., Reed, Steven G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627294/
https://www.ncbi.nlm.nih.gov/pubmed/29263878
http://dx.doi.org/10.1038/s41541-017-0025-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627294/
https://www.ncbi.nlm.nih.gov/pubmed/29263878
http://dx.doi.org/10.1038/s41541-017-0025-5

Ejemplares similares